Nanodiamond as a vector for siRNA delivery to Ewing sarcoma cells.
暂无分享,去创建一个
Thierry Gacoin | Marie-Pierre Adam | Géraldine Dantelle | François Treussart | J. Botsoa | S. Lavielle | T. Gacoin | A. Alhaddad | G. Dantelle | C. Malvy | F. Treussart | J. Bertrand | Marie-Pierre Adam | S. Perruchas | C. Mansuy | Jean-Rémi Bertrand | Claude Malvy | Jacques Botsoa | Solange Lavielle | Sandrine Perruchas | Anna Alhaddad | Christelle Mansuy
[1] A. Goga,et al. Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment , 2011, Science Translational Medicine.
[2] T. Rades,et al. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[3] P. Couvreur,et al. Antisense oligonucleotide nanocapsules efficiently inhibit EWS-Fli1 expression in a Ewing's sarcoma model. , 2006, Oligonucleotides.
[4] S. L. Bridal,et al. The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. , 2010, Biomaterials.
[5] Zhiming Yu,et al. Effect of sodium oleate adsorption on the colloidal stability and zeta potential of detonation synthesized diamond particles in aqueous solutions , 2005 .
[6] J. Boudou,et al. Peptide‐Grafted Nanodiamonds: Preparation, Cytotoxicity and Uptake in Cells , 2008, Chembiochem : a European journal of chemical biology.
[7] Masaki Ozawa,et al. A general procedure to functionalize agglomerating nanoparticles demonstrated on nanodiamond. , 2009, ACS nano.
[8] P. Caliceti,et al. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. , 2003, Advanced drug delivery reviews.
[9] Alderley Park,et al. Pharmaceutical Research , 1957, Canadian journal of comparative medicine and veterinary science.
[10] British Journal of Pharmacology and Chemotherapy , 1946, Nature.
[11] Oligonucleotides Targeted Against a Junction Oncogene Are Made Efficient by Nanotechnologies , 2003, Pharmaceutical Research.
[12] O. Delattre,et al. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] S. Nie,et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.
[14] K. Tanaka,et al. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. , 1997, The Journal of clinical investigation.
[15] Jianing Qi,et al. Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery. , 2010, International journal of pharmaceutics.
[16] C. Malvy,et al. Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles. , 2009, Oligonucleotides.
[17] Yuanwei Chen,et al. Biodistribution and fate of nanodiamonds in vivo , 2009 .
[18] T. Gacoin,et al. Surface-induced charge state conversion of nitrogen-vacancy defects in nanodiamonds , 2010, 1008.2276.
[19] E. Weiss,et al. Proton sponge trick for pH-sensitive disassembly of polyethylenimine-based siRNA delivery systems. , 2010, Bioconjugate chemistry.
[20] C. Malvy,et al. Delivery of Small Interfering RNA. A Review and an Example of Application to a Junction Oncogene , 2008, Tumori.
[21] Matthew J. Rosseinsky,et al. Physical Review B , 2011 .
[22] Huan-Cheng Chang,et al. Mass production and dynamic imaging of fluorescent nanodiamonds. , 2008, Nature nanotechnology.
[23] Bin Ding,et al. Critical Reviews in Solid State and Materials Sciences , 2012 .
[24] L. Balducci. Journal of Clinical Oncology: the next 25 years. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] C. R. Middaugh,et al. Biophysical characterization of PEI/DNA complexes. , 2003, Journal of pharmaceutical sciences.
[26] Gérard Férey,et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.
[27] Dean Ho,et al. Polymer-functionalized Nanodiamond Platforms as Vehicles for Gene Delivery Keywords: Nanodiamonds · Gene Delivery · Nanocarrier · Transfection · Low Molecular Weight Polyethyleneimine (lmw Pei) , 2022 .
[28] Ted M. Lakowski,et al. Analytical Biochemistry , 1960, Nature.
[29] Tiancheng Wang,et al. Pulmonary toxicity and translocation of nanodiamonds in mice , 2010 .
[30] A. Soffer. Journals of Clinical Investigation and Controlled Circulation Periodicals—Fundamental Differences , 1977 .
[31] G. Schatz. The journal of physical chemistry letters , 2009 .
[32] Amanda M. Schrand,et al. Nanodiamond Particles: Properties and Perspectives for Bioapplications , 2009 .
[33] L. Seymour,et al. Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .
[34] G. Schmid. The Nature of Nanotechnology , 2010 .
[35] J. Gilman,et al. Nanotechnology , 2001 .
[36] E. Kaiser,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.
[37] S. Kawakami,et al. The development of a gene vector electrostatically assembled with a polysaccharide capsule. , 2009, Biomaterials.
[38] J. Boudou,et al. Comparison of the photoluminescence properties of semiconductor quantum dots and non-blinking diamond nanoparticles. Observation of the diffusion of diamond nanoparticles in living cells , 2009, 0904.2648.
[39] G. Barratt,et al. Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA , 2009, British journal of pharmacology.
[40] L. Seymour,et al. Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.
[41] Shengrong Guo,et al. Recent progress in nanotechnology for cancer therapy. , 2010, Chinese journal of cancer.
[42] Dean Ho,et al. Nanodiamond Vectors Functionalized with Polyethylenimine for siRNA Delivery , 2010 .
[43] Jinfang Zhi,et al. Nanodiamond as the pH-responsive vehicle for an anticancer drug. , 2010, Small.
[44] Saber M Hussain,et al. Are diamond nanoparticles cytotoxic? , 2007, The journal of physical chemistry. B.
[45] Erik Pierstorff,et al. Active nanodiamond hydrogels for chemotherapeutic delivery. , 2007, Nano letters.
[46] Saji George,et al. Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.
[47] Huan-Cheng Chang,et al. In vivo imaging and toxicity assessments of fluorescent nanodiamonds in Caenorhabditis elegans. , 2010, Nano letters.
[48] H-C Chang,et al. Functionalized fluorescent nanodiamonds for biomedical applications. , 2009, Nanomedicine.
[49] R. Misra,et al. Biomaterials , 2008 .
[50] Amanda S Barnard,et al. Diamond standard in diagnostics: nanodiamond biolabels make their mark. , 2009, The Analyst.
[51] J. Roch,et al. Efficient production of NV colour centres in nanodiamonds using high-energy electron irradiation , 2010 .
[52] P. Couvreur,et al. Pharmacokinetics and Biodistribution of Oligonucleotide Adsorbed onto Poly(isobutylcyanoacrylate) Nanoparticles After Intravenous Administration in Mice , 2004, Pharmaceutical Research.
[53] H. Dai,et al. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.
[54] Elazer R. Edelman,et al. Science Translational Medicine Podcast: 5 May 2010 , 2010, Science Translational Medicine.
[55] Kirk G Scheckel,et al. Surface charge-dependent toxicity of silver nanoparticles. , 2011, Environmental science & technology.
[56] F. Cordelières,et al. A guided tour into subcellular colocalization analysis in light microscopy , 2006, Journal of microscopy.
[57] Elena Perevedentseva,et al. Spectroscopic study of bio-functionalized nanodiamonds , 2006 .
[58] Pascal Aubert,et al. High yield fabrication of fluorescent nanodiamonds , 2009, Nanotechnology.